Viz RV/LV vs Zio XT ECG Monitoring System
AI Verdict
Choose Viz RV/LV if…
Choose Viz RV/LV if your primary need is rapid, AI-driven risk stratification for suspected pulmonary embolism directly from CTPA scans. This tool is ideal for emergency departments and radiology teams requiring immediate, automated RV/LV ratio measurements and seamless care team coordination to accelerate critical treatment decisions.
View Viz RV/LV →Choose Zio XT ECG Monitoring System if…
Choose Zio XT ECG Monitoring System if you require extended, continuous cardiac monitoring for up to 14 days to detect intermittent arrhythmias in an outpatient setting. This wearable biosensor is best suited for patients needing comfortable, long-term ECG data collection without external wires, enabling accurate diagnosis of elusive cardiac events.
View Zio XT ECG Monitoring System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Viz RV/LV | Zio XT ECG Monitoring System |
|---|---|---|
| Pricing | Not publicly available | Contact for pricing |
| Deployment | Cloud-based | Cloud-based (AWS EC2 platform), no on-premise hardware required. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz RV/LVViz RV/LV enhances clinical usability by automating critical measurements from CTPA scans and integrating seamlessly into existing workflows. Its AI-powered alerts, mobile DICOM viewer, and HIPAA-compliant communication platform streamline care coordination for multiple clinical users, improving overall efficiency in acute settings.
Clinical Value
Viz RV/LVViz RV/LV provides a crucial RV/LV ratio for rapid pulmonary embolism risk stratification, directly impacting immediate, potentially life-saving treatment decisions for an acute, critical condition. While Zio XT offers significant value in detecting elusive arrhythmias over time, Viz RV/LV's direct contribution to acute patient management in a high-stakes scenario gives it a slight edge in immediate clinical impact.
Pricing & Value
Zio XT ECG Monitoring SystemZio XT provides specific pricing details, including UK costs and US Medicare reimbursement rates, offering transparency for potential buyers to assess its value proposition. In contrast, Viz RV/LV's pricing information is not publicly available, making it impossible to evaluate its cost-effectiveness or value without direct inquiry.
Enterprise Readiness
Viz RV/LVViz RV/LV is designed as a 'seamless component of the Viz PE Solution' with 'AI-powered alerts and notifications to care teams' and a 'HIPAA-compliant communication platform,' indicating robust integration into hospital systems and workflows. While Zio XT is cloud-based and HIPAA compliant, Viz RV/LV's explicit focus on inter-departmental care coordination and workflow optimization demonstrates a more comprehensive approach to enterprise deployment.
Innovation
Zio XT ECG Monitoring SystemThe Zio XT ECG Monitoring System introduces a significant innovation with its wearable, single-lead biosensor for up to 14 days of continuous, comfortable cardiac monitoring, combined with FDA-cleared deep-learned AI. This approach offers a paradigm shift in long-term cardiac diagnostics, improving patient experience and diagnostic yield compared to traditional methods. Viz RV/LV's automation of CTPA measurements is valuable but less disruptive to the overall diagnostic process.
Support & Docs
TieBoth Viz.ai and iRhythm Technologies are established companies offering FDA-cleared medical devices, implying they both provide standard levels of customer support and documentation. Without specific comparative details on their support channels, response times, or documentation comprehensiveness, it is not possible to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Viz RV/LV | Zio XT ECG Monitoring System |
|---|---|---|
| Name | Viz RV/LV | Zio XT ECG Monitoring System |
| Company | Viz.ai | iRhythm Technologies |
| Primary Function | Automates right and left ventricular diameter measurements from CTPA scans for rapid pulmonary embolism risk stratification and enhanced care coordination. | Wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring for accurate arrhythmia detection and diagnosis. |
| Core Technology/Input | AI algorithm analyzing volumetric CTPA acquisitions for identification and measurement of heart ventricles. | Wearable single-lead ECG biosensor with proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis. |
| Target Condition/Application | Pulmonary embolism risk stratification and detection. | Arrhythmia detection and diagnosis. |
| Specialties Supported | Emergency Medicine, Pulmonology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Viz RV/LV and Zio XT ECG Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring Viz RV/LV or Zio XT ECG Monitoring System
Backers
Who funded each tool's parent company.